EXTENDED INTERVAL DOSING OF OCRELIZUMAB REDUCES RISK OF DEVELOPING HYPOGAMMAGLOBULINAEMIA

被引：2
|
作者：
Allen, Christopher [1 ]
Russell, Melanie [2 ]
Pendlebury, Jessica [3 ]
Vollmer, Brandi [4 ]
Moswela, Olivia [5 ]
Raza, Pranee-Ta [6 ]
Garjani, Afagh
Abdel-Fahim, Rasha [7 ]
Tallantyre, Emma [8 ]
Evangelou, Nikos [1 ]
机构：
[1] Univ Nottingham, Nottingham, England
[2] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England
[3] Salford Royal NHS Fdn Trust, Salford, Lancs, England
[4] Univ Colorado, Dept Neurol, Boulder, CO USA
[5] Oxford Univ Hosp NHS Fdn Trust, Oxford, England
[6] Cleveland Clin, Cleveland, OH USA
[7] Nottingham Univ Hosp NHS Trust, Nottingham, England
[8] Cardiff Univ, Div Psychol Med & Clin Neurosci, Cardiff, Wales
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2022年 / 93卷 / 09期
关键词：
D O I：
10.1136/jnnp-2022-abn2.26
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Determination of extended-interval gentamicin dosing for neonatal patients in developing countries
    Darmstadt, Gary L.
    Hossain, M. Monir
    Jana, Atanu Kumar
    Saha, Samir K.
    Choi, Yoonjoung
    Sridhar, S.
    Thomas, Niranjan
    Miller-Bell, Mary
    Edwards, David
    Aranda, Jacob
    Willis, Jefftey
    Coffey, Patricia
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (06) : 501 - 507
  • [22] Exploratory PML risk assessment on Extended Interval Natalizumab Dosing.
    Ryerson, Lana Zhovtis
    Foley, John
    Kister, Ilya
    Frohman, Teresa
    Pandey, Krupa
    Lu, Xiaochun
    Goldberg, Judith
    Zuniga-Estrada, Guadalupe
    Hoyt, Tammy
    Jacob, April
    Bacon, Tamar
    Major, Eugene
    Frohman, Elliot
    NEUROLOGY, 2017, 88
  • [23] Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis
    Venet, Melany
    Lepine, Anne
    Maarouf, Adil
    Biotti, Damien
    Boutiere, Clemence
    Casez, Olivier
    Cohen, Mikael
    Durozard, Pierre
    Demortiere, Sarah
    Giorgi, Laetitia
    Maillart, Elisabeth
    Mathey, Guillaume
    Mazzola, Laure
    Rico, Audrey
    Camdessanche, Jean-Philippe
    Deiva, Kumaran
    Pelletier, Jean
    Audoin, Bertrand
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (02) : 261 - 265
  • [24] Extended interval gentamicin dosing in obstetrics
    Li, C.
    Hardy, E.
    Moreno, K.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (02) : S774 - S774
  • [25] Extended-interval dosing of aminoglycosides
    Blam, ME
    Hammer, GS
    MOUNT SINAI JOURNAL OF MEDICINE, 1997, 64 (06): : 386 - 391
  • [26] Effectiveness of Natalizumab in Extended Dosing Interval
    Hervas, Jose Vicente
    Punet-Ortiz, Joan
    Teniente-Serra, Aina
    Mansilla, M. Jos
    Quirant-Sanchez, Bibiana
    Navarro, Juan
    Presas, Silvia
    Martinez-Caceres, Eva
    Ramo, Cristina
    NEUROLOGY, 2016, 86
  • [27] Effectiveness of natalizumab in extended dosing interval
    Ramo-Tello, C.
    Grau-Lopez, L.
    Vilaro, L.
    Segui, C.
    Delicado, S.
    Bonafont, X.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 213 - 214
  • [28] Extended-interval dosing of gentamicin for treatment of neonatal sepsis in developed and developing countries
    Darmstadt, Gary L.
    Miller-Bell, Mary
    Batra, Maneesh
    Law, Paul
    Law, Kiely
    JOURNAL OF HEALTH POPULATION AND NUTRITION, 2008, 26 (02) : 163 - 182
  • [29] Switch to ocrelizumab in MS patients treated with natalizumab in extended interval dosing at high risk of PML: A 96-week follow-up pilot study
    Santiago-Setien, Pilar
    Barquin-Rego, Cristina
    Hernandez-Martinez, Paula
    Ezquerra-Marigomez, Maria
    Torres-Barquin, Marta
    Menendez-Garcia, Cristina
    Uriarte, Fernando
    Jimenez-Lopez, Yesica
    Misiego, Mercedes
    de la Torre, Jose Ramon Sanchez
    Setien, Sonia
    Delgado-Alvarado, Manuel
    Riancho, Javier
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [30] Clinical and Immunological Impact of Ocrelizumab Extended Interval Dosing in Multiple Sclerosis: A Single-Center, Real-World Experience
    Nasello, Martina
    Zancan, Valeria
    Rinaldi, Virginia
    Marrone, Antonio
    Renie, Roberta
    Diamant, Selene
    Marconi, Martina
    Le Mura, Lorenzo
    Salvetti, Marco
    Buscarinu, Maria Chiara
    Bellucci, Gianmarco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)
12345